Literature DB >> 8682470

Hepatic blood flow after acute biliary obstruction and drainage in conscious dogs.

H Kanda1, Y Nimura, A Yasui, T Uematsu, S Kamiya, Y Machiki, Y Kitagawa, S Shionoya.   

Abstract

BACKGROUND AIMS: Obstructive jaundice is a factor which effects hepatic blood flow and the relative contribution of the hepatic arterial flow and portal venous flow. In this study, and were measured in conscious dogs and the influence of biliary obstruction and drainage was investigated.
MATERIAL AND METHODS: Hepatic arterial flow (HAF) and portal venous flow (PVF) after biliary obstruction and subsequent drainage were continuously measured in conscious dogs using implantable transit time ultrasonic flow-meters.
RESULTS: After biliary obstruction hepatic arterial flow rapidly increased compared to the pre-obstructed values(p < 0.01), while portal venous flow was significantly decreased (p < 0.01). Total hepatic blood flow was initially increased (p < 0.01) until 2 hours after obstruction. It then decreased gradually. After 2 weeks, it was less than the pre-obstructed values, but this was not significant. Biliary drainage was performed after 2 weeks. Hepatic arterial flow subsequently decreased (p < 0.01) and portal venous flow increased (p < 0.05). Blood flow did not change.
CONCLUSION: Biliary obstruction resulted in significant changes in liver circulation. Biliary drainage facilitated recovery from these changes.

Entities:  

Mesh:

Year:  1996        PMID: 8682470

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

Review 1.  Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review.

Authors:  Y Yokoyama; M Nagino; Y Nimura
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

Review 2.  An analytical review of vasculobiliary injury in laparoscopic and open cholecystectomy.

Authors:  Steven M Strasberg; W Scott Helton
Journal:  HPB (Oxford)       Date:  2010-11-15       Impact factor: 3.647

3.  The effects of L-arginine on liver damage in experimental acute cholestasis an immunohistochemical study.

Authors:  Yucel Ozsoy; Mustafa Ozsoy; Teoman Coskun; Kaya Yavuz; Kemal Ozbilgin; Kemal Namlı; Ahmet Var; Beyhan Ozyurt
Journal:  HPB Surg       Date:  2011-06-01

4.  Uneven acute non-alcoholic fatty change of the liver after percutaneous transhepatic portal vein embolization in a patient with hilar cholangiocarcinoma - a case report.

Authors:  Chun-Yi Tsai; Motoi Nojiri; Yukihiro Yokoyama; Tomoki Ebata; Takashi Mizuno; Masato Nagino
Journal:  BMC Gastroenterol       Date:  2017-12-06       Impact factor: 3.067

5.  Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers.

Authors:  Jimme K Wiggers; Rowan F van Golen; Joanne Verheij; Annemiek M Dekker; Thomas M van Gulik; Michal Heger
Journal:  BMC Surg       Date:  2017-04-11       Impact factor: 2.102

6.  The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial.

Authors:  Jin-Chao Song; Hao Gao; Hai-Bo Qiu; Qian-Bo Chen; Mei-Hua Cai; Ma-Zhong Zhang; Zhi-Jie Lu
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

7.  Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver Dysfunction.

Authors:  Xiao-Nan Gao; Xu-Yang Nie; Jing-Lin Gao; Tian-Fang Heng; Yu-Qi Zhang; Li Hua; Ya-Qi Sun; Zhang-Ying Feng; Ming-Xia Wang; Li Jia
Journal:  Drug Des Devel Ther       Date:  2022-07-26       Impact factor: 4.319

8.  Bile duct obstruction associated with pancreatitis in 46 dogs.

Authors:  Ashley R Wilkinson; Stefanie M DeMonaco; David L Panciera; Cristiane C Otoni; Michael S Leib; Martha M Larson
Journal:  J Vet Intern Med       Date:  2020-08-27       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.